Shanghai Healthcare Capital
Asia, Shanghai, China, Huangpu'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Shanghai Healthcare Capital invests in healthcare ventures and focuses on innovative solutions and growth opportunities in the industry.
Investor Profile
Shanghai Healthcare Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series D, Series A rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Pharmaceutical, Biotechnology, Life Science.
Stage Focus
- Series B (33%)
- Series D (33%)
- Series A (33%)
Country Focus
- China (67%)
- United States (33%)
Industry Focus
- Pharmaceutical
- Biotechnology
- Life Science
- Health Care
- Therapeutics
- Cloud Computing
- Dsp
- Manufacturing
- Semiconductor
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.